공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

의료용 대마 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년)

Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 04월 상품 코드 999811
페이지 정보 영문 116 Pages
가격
US $ 2,299 ₩ 2,638,000 PDF (Single User License)
US $ 3,399 ₩ 3,900,000 PDF (5 User License)
US $ 4,499 ₩ 5,162,000 PDF (Corporate License)


의료용 대마 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년) Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 04월 페이지 정보 : 영문 116 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의료용 대마 시장은 2015-2020년간 강력하게 성장했습니다. 대마는 대마과 대마식물에 유래하는 향정신약입니다. 그것은 고대 인도, 중국, 이집트, 이슬람 문화에서 약용으로 사용되었습니다. 현재 대마는 암, 만성 통증, 우울증, 관절염, 당뇨병, 녹내장, 편두통, 간질, 다발성 경화증, 후천성면역결핍증(AIDS), 루게릭병(ALS), 알츠하이머병, 외상후 스트레스 장애(PTSD), 파킨슨병, 투렛병 등 다양한 질환이나 증상의 치료에 적용되고 있습니다. 그 치료상 이점 때문에 대마는 아르헨티나, 브라질, 캐나다, 칠레, 콜롬비아, 체코, 독일, 이탈리아, 멕시코, 스페인, 영국, 미국, 우루과이 등 많은 국가에서 의료 용도로서 승인되고 있으며, 다양한 법적 제한이 있습니다. 세계의 의료용 대마 시장은 2021-2026년간 15.3%의 CAGR로 확대될 것으로 예상됩니다.

세계의 의료용 대마 시장 성장 촉진요인:

  • 대마는 다른 치료 옵션과 비교해 더 안전하고, 증상이 심한 부작용이 적습니다. 또한 다른 치료법과 병용하여 그 유효성을 높이거나 유해한 부작용에 대항할 수도 있습니다. 예를 들면 화학요법 환자의 메스꺼움을 줄이고, 식욕을 증진하는데 매우 효과적입니다. 마찬가지로 기존 오피오이드 진통제와 조합해 사용하여 환자는 오피오이드 투여량과 빈도를 크게 줄일 수 있고, 더 큰 통증 완화를 가져옵니다.
  • 고령의 환자는 만성질환을 발병할 가능성이 높고, 더 많은 의사의 진찰을 필요로 하기 때문에 세계에서 꾸준히 고령화하는 인구는 의료용 대마 수요를 촉진하는데 있어서 중요한 역할을 수행하고 있습니다.
  • 대마 기반 적응증의 임상시험, 연구개발(R&D) 활동 및 상품화는 시장 성장을 촉진할 것으로 기대되고 있습니다.
  • 건강 제품에 대한 지출은 변동의 영향을 받기 어렵지만, 의료용 마리화나의 섭취는 기존에 없던 성질 때문에 가처분 소득 변화를 일으키기 쉽습니다. 그 결과 가처분 소득 증가는 의료용 대마 수요에 플러스 영향을 미칠 것으로 예측됩니다.

세계의 의료용 대마(Medical Cannabis) 시장에 대해 조사했으며, 업계 동향, 시장 예측, 종류·파생물·용도·최종 용도·투여 경로·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서문

제2장 범위와 조사 방법

제3장 주요 요약

제4장 서론

제5장 세계의 의료용 대마 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 종류별 시장 세분화
  • 파생물별 시장 세분화
  • 용도별 시장 세분화
  • 최종 용도별 시장 세분화
  • 투여 경로별 시장 세분화
  • 지역별 시장 세분화
  • SWOT 분석
    • 개요
    • 강점
    • 약점
    • 시장 기회
    • 위협
  • 밸류체인 분석
    • 원재료 공급업체
    • 수집업체
    • 제조업체
    • 유통업체
    • 수출업체
    • 소매업체
    • 최종사용자
  • Porters Five Forces 분석
  • 주요 성공요인과 위험요인

제6장 종류별 시장 세분화

  • 인디카
  • 사티바
  • 하이브리드

제7장 파생물별 시장 세분화

  • 칸나비디올(CBD)
  • 테트라하이드로칸나비놀(THC)
  • 기타

제8장 용도별 시장 세분화

  • 관절염
  • 편두통
  • 간질
  • 기타

제9장 최종 용도별 시장 세분화

  • 제약 업계
  • 연구개발 센터
  • 기타

제10장 투여 경로별 시장 세분화

  • 경구 액제와 캡슐
  • 흡연
  • 기화기
  • 국소
  • 기타

제11장 지역별 시장 세분화

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 이탈리아
    • 프랑스
    • 네덜란드
    • 스페인
  • 라틴아메리카
  • 아시아태평양
  • 중동 및 아프리카

제12장 다양한 적응증에 걸쳐 의료용 대마의 이점을 시사하는 임상 조사 개요

  • 알츠하이머병
  • 자폐증
  • 만성 통증
  • 간질
  • 편두통
  • 소화기질환
  • 다발성 경화증
  • 정신분열증
  • 기타

제13장 경쟁 상황

  • 시장 구조
  • 주요 기업

제14장 주요 기업 개요

KSM 21.04.28

List of Figures

  • Figure 1: Global: Medical Cannabis Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Cannabis Market: Value Trends (in Billion US$), 2015-2020
  • Figure 3: Global: Medical Cannabis Market: Breakup by Species (in %), 2020
  • Figure 4: Global: Medical Cannabis Market: Breakup by Derivative (in %), 2020
  • Figure 5: Global: Medical Cannabis Market: Breakup by Application (in %), 2020
  • Figure 6: Global: Medical Cannabis Market: Breakup by End-Use (in %), 2020
  • Figure 7: Global: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
  • Figure 8: Global: Medical Cannabis Market: Breakup by Region (in %), 2020
  • Figure 9: Global: Medical Cannabis Market Forecast: Value Trends (in Billion US$), 2021-2026
  • Figure 10: Global: Medical Cannabis Industry: SWOT Analysis
  • Figure 11: Global: Medical Cannabis Industry: Value Chain Analysis
  • Figure 12: Global: Medical Cannabis Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Medical Cannabis Market (Indica): Value Trends (in Million US$), 2015 & 2020
  • Figure 14: Global: Medical Cannabis Market Forecast (Indica): Value Trends (in Million US$), 2021-2026
  • Figure 15: Global: Medical Cannabis Market (Sativa): Value Trends (in Million US$), 2015 & 2020
  • Figure 16: Global: Medical Cannabis Market Forecast (Sativa): Value Trends (in Million US$), 2021-2026
  • Figure 17: Global: Medical Cannabis Market (Hybrid): Value Trends (in Million US$), 2015 & 2020
  • Figure 18: Global: Medical Cannabis Market Forecast (Hybrid): Value Trends (in Million US$), 2021-2026
  • Figure 19: Global: Medical Cannabis Market (Cannabidiol-CBD): Value Trends (in Million US$), 2015 & 2020
  • Figure 20: Global: Medical Cannabis Market Forecast (Cannabidiol-CBD): Value Trends (in Million US$), 2021-2026
  • Figure 21: Global: Medical Cannabis Market (Tetrahydrocannabinol-THC): Value Trends (in Million US$), 2015 & 2020
  • Figure 22: Global: Medical Cannabis Market Forecast (Tetrahydrocannabinol-THC): Value Trends (in Million US$), 2021-2026
  • Figure 23: Global: Medical Cannabis Market (Other Derivatives): Value Trends (in Million US$), 2015 & 2020
  • Figure 24: Global: Medical Cannabis Market Forecast (Other Derivatives): Value Trends (in Million US$), 2021-2026
  • Figure 25: Global: Medical Cannabis Market (Application in Cancer): Value Trends (in Million US$), 2015 & 2020
  • Figure 26: Global: Medical Cannabis Market Forecast (Application in Cancer): Value Trends (in Million US$), 2021-2026
  • Figure 27: Global: Medical Cannabis Market (Application in Arthritis): Value Trends (in Million US$), 2015 & 2020
  • Figure 28: Global: Medical Cannabis Market Forecast (Application in Arthritis): Value Trends (in Million US$), 2021-2026
  • Figure 29: Global: Medical Cannabis Market (Application in Migraine): Value Trends (in Million US$), 2015 & 2020
  • Figure 30: Global: Medical Cannabis Market Forecast (Application in Migraine): Value Trends (in Million US$), 2021-2026
  • Figure 31: Global: Medical Cannabis Market (Application in Epilepsy): Value Trends (in Million US$), 2015 & 2020
  • Figure 32: Global: Medical Cannabis Market Forecast (Application in Epilepsy): Value Trends (in Million US$), 2021-2026
  • Figure 33: Global: Medical Cannabis Market (Other Applications): Value Trends (in Million US$), 2015 & 2020
  • Figure 34: Global: Medical Cannabis Market Forecast (Other Applications): Value Trends (in Million US$), 2021-2026
  • Figure 35: Global: Medical Cannabis Market (End-Use in Pharmaceutical Industry): Value Trends (in Million US$), 2015 & 2020
  • Figure 36: Global: Medical Cannabis Market Forecast (End-Use in Pharmaceutical Industry): Value Trends (in Million US$), 2021-2026
  • Figure 37: Global: Medical Cannabis Market (End-Use in Research and Development Centres): Value Trends (in Million US$), 2015 & 2020
  • Figure 38: Global: Medical Cannabis Market Forecast (End-Use in Research and Development Centres): Value Trends (in Million US$), 2021-2026
  • Figure 39: Global: Medical Cannabis Market (Other End-Uses): Value Trends (in Million US$), 2015 & 2020
  • Figure 40: Global: Medical Cannabis Market Forecast (Other End-Uses): Value Trends (in Million US$), 2021-2026
  • Figure 41: Global: Medical Cannabis Market (Administration through Oral Solutions and Capsules): Value Trends (in Million US$), 2015 & 2020
  • Figure 42: Global: Medical Cannabis Market Forecast (Administration through Oral Solutions and Capsules): Value Trends (in Million US$), 2021-2026
  • Figure 43: Global: Medical Cannabis Market (Administration through Smoking): Value Trends (in Million US$), 2015 & 2020
  • Figure 44: Global: Medical Cannabis Market Forecast (Administration through Smoking): Value Trends (in Million US$), 2021-2026
  • Figure 45: Global: Medical Cannabis Market (Administration through Vaporizers): Value Trends (in Million US$), 2015 & 2020
  • Figure 46: Global: Medical Cannabis Market Forecast (Administration through Vaporizers): Value Trends (in Million US$), 2021-2026
  • Figure 47: Global: Medical Cannabis Market (Administration through Topicals): Value Trends (in Million US$), 2015 & 2020
  • Figure 48: Global: Medical Cannabis Market Forecast (Administration through Topicals): Value Trends (in Million US$), 2021-2026
  • Figure 49: Global: Medical Cannabis Market (Other Route of Administration): Value Trends (in Million US$), 2015 & 2020
  • Figure 50: Global: Medical Cannabis Market Forecast (Other Route of Administration): Value Trends (in Million US$), 2021-2026
  • Figure 51: North America: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 52: North America: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 53: United States: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 54: United States: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 55: Canada: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 56: Canada: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 57: Europe: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 58: Europe: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 59: Germany: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 60: Germany: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 61: Italy: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 62: Italy: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 63: France: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 64: France: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 65: Netherlands: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 66: Netherlands: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 67: Spain: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 68: Spain: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 69: Latin America: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 70: Latin America: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 71: Asia Pacific: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 72: Asia Pacific: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026
  • Figure 73: Middle East and Africa: Medical Cannabis Market: Value Trends (in Million US$), 2015 & 2020
  • Figure 74: Middle East and Africa: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Medical Cannabis Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Medical Cannabis Market Forecast: Breakup by Species (in Million US$), 2021-2026
  • Table 3: Global: Medical Cannabis Market Forecast: Breakup by Derivative (in Million US$), 2021-2026
  • Table 4: Global: Medical Cannabis Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 5: Global: Medical Cannabis Market Forecast: Breakup by End-Use (in Million US$), 2021-2026
  • Table 6: Global: Medical Cannabis Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
  • Table 7: Global: Medical Cannabis Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 8: Global: Medical Cannabis Market: Market Structure
  • Table 9: Global: Medical Cannabis Market: Key Players

The global medical cannabis market exhibited strong growth during 2015-2020. Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. It was used medicinally in ancient Indian, Chinese, Egyptian and Islamic cultures. Nowadays, cannabis finds application in the treatment of a wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), Alzheimer's, post-traumatic stress disorder (PTSD), Parkinson's and Tourette's. Owing to its therapeutic benefits, cannabis has been approved for medical use in numerous countries, with varying degrees of legal restrictions. Some of these countries include Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, Italy, Mexico, Spain, the United Kingdom, the United States and Uruguay. Looking forward, IMARC Group expects the global medical cannabis market to grow at a CAGR of 15.3% during 2021-2026.

Global Medical Cannabis Market Drivers:

  • Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief.
  • The steadily aging population across the globe has played a significant role in driving the demand for medical cannabis as geriatric patients are more likely to develop chronic illnesses and require more physician visits.
  • Clinical trials, research and development (R&D) activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market.
  • Although expenditure on health products is less susceptible to fluctuations, the uptake of medical marijuana is liable to changes in disposable income due to its unconventional nature. As a result, increasing disposable incomes are projected to create a positive impact on the demand for medical cannabis.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global medical cannabis market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, species, derivatives, application, end-use, and route of administration.

Breakup by Species:

  • On the basis of species, the market has been segmented as cannabis Indica, Sativa and hybrid. Currently, Cannabis Indica dominates the market, holding the largest share. It is often used in the treatment of insomnia, relaxing the muscles, relieving body pains, headaches and migraines.

Breakup by Derivatives:

  • Based on derivatives, the market has been divided into cannabidiol (CBD), tetrahydrocannabinol (THC) and others. CBD is majorly used for medical purposes due to its non-psychotic effect and low levels of toxicity, whereas THC is utilized to reduce the side-effects of AIDS and cancer treatment.

Breakup by Application:

  • The market has also been divided on the basis of application; wherein cancer represents the leading category. Other major applications of cannabis include arthritis, migraine, epilepsy and others.

Breakup by End-Use:

  • On the basis of end-use, the market has been segregated into the pharmaceutical industry, research and development centers, and others. Currently, the pharmaceutical industry represents the biggest end user.

Breakup by Route of Administration:

  • Based on the route of administration, the market has been categorized into oral solutions and capsules, smoking, vaporizers, topicals and others. Oral solutions and capsules represent the biggest segment, accounting for the largest market share.

Regional Insights:

  • On the geographical front, North America (the United States and Canada) enjoys the leading position in the market. The recent legalization of cannabis in North America for both recreational and medical purposes has been a major driver of the market growth. Other key regions include Europe (Germany, Italy, France, the Netherlands and Spain), Asia Pacific, Latin America, and Middle East and Africa.

Competitive Landscape:

The report has also examined the competitive landscape of the market. Some of the major players include:

  • Canopy Growth Corporation
  • GW Pharmaceuticals, plc
  • Aurora Cannabis, Inc.
  • Aphria, Inc.
  • MedReleaf Corporation
  • Insys Therapeutics, Inc.
  • CanniMed Therapeutics, Inc.
  • Cara Therapeutics, Inc.
  • United Cannabis Corporation

Key Questions Answered in This Report:

  • 1. What is the market size for the global medical cannabis market?
  • 2. What is the global medical cannabis market growth?
  • 3. What are the global medical cannabis market drivers?
  • 4. What are the key industry trends in the global medical cannabis market?
  • 5. What is the impact of COVID-19 on the global medical cannabis market?
  • 6. What is the global medical cannabis market breakup by species?
  • 7. What is the global medical cannabis market breakup by derivatives?
  • 8. What is the global medical cannabis market breakup by application?
  • 9. What is the global medical cannabis market breakup by end-use?
  • 10. What is the global medical cannabis market breakup by route of administration?
  • 11. What are the major regions in the global medical cannabis market?
  • 12. Who are the key companies/players in the global medical cannabis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Cannabis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Species
  • 5.5 Market Breakup by Derivative
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-Use
  • 5.8 Market Breakup by Route of Administration
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast
  • 5.11 SWOT Analysis
    • 5.11.1 Overview
    • 5.11.2 Strengths
    • 5.11.3 Weaknesses
    • 5.11.4 Opportunities
    • 5.11.5 Threats
  • 5.12 Value Chain Analysis
    • 5.12.1 Input Suppliers
    • 5.12.2 Collectors
    • 5.12.3 Manufacturers
    • 5.12.4 Distributors
    • 5.12.5 Exporters
    • 5.12.6 Retailers
    • 5.12.7 End-User
  • 5.13 Porters Five Forces Analysis
    • 5.13.1 Overview
    • 5.13.2 Bargaining Power of Buyers
    • 5.13.3 Bargaining Power of Suppliers
    • 5.13.4 Degree of Competition
    • 5.13.5 Threat of New Entrants
    • 5.13.6 Threat of Substitutes
  • 5.14 Key Success and Risk Factors

6 Market Breakup by Species

  • 6.1 Indica
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sativa
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hybrid
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Derivative

  • 7.1 Cannabidiol (CBD)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tetrahydrocannabinol (THC)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Arthritis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Migraine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Epilepsy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-Use

  • 9.1 Pharmaceutical Industry
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research and Development Centres
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Route of Administration

  • 10.1 Oral Solutions and Capsules
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Smoking
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Vaporizers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Topicals
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Italy
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 France
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Netherlands
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
  • 11.3 Latin America
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Asia Pacific
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications

  • 12.1 Alzheimer's Disease
  • 12.2 Autism
  • 12.3 Cancer
  • 12.4 Chronic Pain
  • 12.5 Epilepsy
  • 12.6 Migraine
  • 12.7 Digestive Disorders
  • 12.8 Multiple Sclerosis
  • 12.9 Schizophrenia
  • 12.10 Others

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players

14 Key Player Profiles

Back to Top
전화 문의
F A Q